Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Sep-24 6:29 PM View:  | Godwin Mary E. Senior VP, Operations | Nautilus Biotechnology, Inc. (NAUT) | 23-Sep-24 | Option Exercise | 47,031 | $0.46 | $21,634.30 | 100% 0 to 47.03K | |
| 25-Sep-24 6:29 PM View: | Godwin Mary E. Senior VP, Operations | Nautilus Biotechnology, Inc. (NAUT) | 23-Sep-24 | Option Sale | 47,031 | $2.87 | $134,744.00 | (100%) 47.03K to 0 | |
| 18-Sep-24 6:32 PM View: | Godwin Mary E. Senior VP, Operations | Nautilus Biotechnology, Inc. (NAUT) | 17-Sep-24 | Option Sale | 35,000 | $2.85 | $99,869.00 | (100%) 35.0K to 0 | |
| 18-Sep-24 6:32 PM View: | Godwin Mary E. Senior VP, Operations | Nautilus Biotechnology, Inc. (NAUT) | 17-Sep-24 | Option Exercise | 35,000 | $0.46 | $16,100.00 | 100% 0 to 35.0K | |
| 11-Mar-24 8:21 PM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 11-Mar-24 | Purchase | 12,044 | $2.84 | $34,215.80 | < 1% 17.15M to 17.16M | |
| 11-Mar-24 8:21 PM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 08-Mar-24 | Private Purchase | 2,430 | $2.99 | $7,262.06 | < 1% 17.14M to 17.15M | |
| 07-Mar-24 7:06 PM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 07-Mar-24 | Purchase | 18,854 | $2.89 | $54,424.00 | < 1% 17.13M to 17.14M | |
| 07-Mar-24 7:06 PM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 06-Mar-24 | Purchase | 9,267 | $2.70 | $25,033.90 | < 1% 17.12M to 17.13M | |
| 07-Mar-24 7:06 PM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 05-Mar-24 | Private Purchase | 7,405 | $2.65 | $19,596.60 | < 1% 17.11M to 17.12M | |
| 28-Sep-22 4:01 PM View: | Sankar Subramanian Senior VP, Product Development | Nautilus Biotechnology, Inc. (NAUT) | 27-Sep-22 | Purchase | 5,000 | $2.03 | $10,149.00 | 6% 86.25K to 91.25K | |
| 28-Sep-22 4:01 PM View: | Sankar Subramanian Senior VP, Product Development | Nautilus Biotechnology, Inc. (NAUT) | 26-Sep-22 | Private Purchase | 10,000 | $2.03 | $20,250.00 | 13% 76.25K to 86.25K | |
| 26-Sep-22 9:26 PM View: | Weld Gwen E Chief People Officer | Nautilus Biotechnology, Inc. (NAUT) | 23-Sep-22 | Private Purchase | 30,000 | $2.03 | $60,765.00 | 100% 0 to 30.0K | |
| 19-Sep-22 5:50 PM View: | Sankar Subramanian Senior VP, Product Development | Nautilus Biotechnology, Inc. (NAUT) | 16-Sep-22 | Purchase | 35,000 | $2.16 | $75,446.00 | 88% 40.0K to 75.0K | |
| 19-Sep-22 5:50 PM View: | Sankar Subramanian Senior VP, Product Development | Nautilus Biotechnology, Inc. (NAUT) | 15-Sep-22 | Private Purchase | 40,000 | $2.19 | $87,752.00 | 100% 0 to 40.0K | |
| 22-Aug-22 7:40 PM View: | Mowry Anna CFO and Treasurer | Nautilus Biotechnology, Inc. (NAUT) | 19-Aug-22 | Private Purchase | 17,500 | $2.30 | $40,218.50 | 45% 39.25K to 56.75K | |
| 16-Aug-22 8:19 PM View: | Murphy Matthew B. General Counsel | Nautilus Biotechnology, Inc. (NAUT) | 15-Aug-22 | Purchase | 7,500 | $2.84 | $21,307.50 | 16% 47.89K to 55.39K | |
| 16-Aug-22 8:19 PM View: | Murphy Matthew B. General Counsel | Nautilus Biotechnology, Inc. (NAUT) | 12-Aug-22 | Private Purchase | 2,500 | $2.85 | $7,125.00 | 6% 45.39K to 47.89K | |
| 08-Aug-22 7:48 PM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 08-Aug-22 | Purchase | 8,346 | $2.93 | $24,443.80 | < 1% 17.1M to 17.11M | |
| 08-Aug-22 7:48 PM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 05-Aug-22 | Private Purchase | 41,654 | $2.92 | $121,646.00 | < 1% 17.06M to 17.1M | |
| 28-Jun-22 6:17 PM View: | Mowry Anna CFO and Treasurer | Nautilus Biotechnology, Inc. (NAUT) | 27-Jun-22 | Private Purchase | 5,500 | $2.75 | $15,124.50 | 16% 33.75K to 39.25K | |
| 13-May-22 5:09 PM View: | Murphy Matthew B. General Counsel | Nautilus Biotechnology, Inc. (NAUT) | 12-May-22 | Grant | 10,000 | $3.28 | $32,800.00 | 29% 34.14K to 44.14K | |
| 10-May-22 8:28 PM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 09-May-22 | Private Purchase | 50,000 | $3.96 | $198,000.00 | < 1% 17.01M to 17.06M | |
| 04-Mar-22 5:39 PM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 04-Mar-22 | Option Exercise | 100 | $10.00 | $1,000.00 | < 1% 17.01M to 17.01M | |
| 04-Mar-22 5:39 PM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 03-Mar-22 | Private Purchase | 50,000 | $3.60 | $179,890.00 | < 1% 16.96M to 17.01M | |
| 21-Dec-21 5:40 PM View: | Mallick Parag Chief Scientist Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 21-Dec-21 | Gift | 210,000 | -- | -- | (1%) 20.69M to 20.48M | |
| 10-Dec-21 4:05 PM View: | Perceptive Advisors LLC Director | Nautilus Biotechnology, Inc. (NAUT) | 08-Dec-21 | Market Purchase | 200,000 | $5.36 | $1,072,000.00 | 2% 8.91M to 9.11M | (< 1%) |
| 01-Dec-21 9:41 PM View: | Posard Matthew L. Director | Nautilus Biotechnology, Inc. (NAUT) | 01-Dec-21 | Market Purchase | 30,000 | $4.47 | $134,105.00 | 25% 120.0K to 150.0K | 8% |
| 02-Dec-21 8:49 AM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 01-Dec-21 | Market Purchase | 88,022 | $4.73 | $416,397.00 | < 1% 16.87M to 16.96M | (6%) |
| 02-Dec-21 8:49 AM View: | Patel Sujal M CEO, President, and Secretary Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 30-Nov-21 | Market Purchase | 161,978 | $4.72 | $764,779.00 | < 1% 16.71M to 16.87M | (6%) |
| 01-Dec-21 9:41 PM View: | Posard Matthew L. Director | Nautilus Biotechnology, Inc. (NAUT) | 30-Nov-21 | Market Purchase | 20,000 | $4.57 | $91,400.00 | 20% 100.0K to 120.0K | 6% |
| 24-Nov-21 5:12 PM View: | Mowry Anna CFO and Treasurer | Nautilus Biotechnology, Inc. (NAUT) | 24-Nov-21 | Private Purchase | 15,000 | $4.58 | $68,632.50 | 86% 17.5K to 32.5K | < 1% |
| 17-Nov-21 8:19 PM View: | McIlwain Matthew S Director | Nautilus Biotechnology, Inc. (NAUT) | 15-Nov-21 | Market Purchase | 100,000 | $5.30 | $529,890.00 | 2% 6.38M to 6.48M | (4%) |
| 26-Aug-21 7:29 PM View: | McIlwain Matthew S Director | Nautilus Biotechnology, Inc. (NAUT) | 26-Aug-21 | Market Purchase | 11,709 | $7.71 | $90,313.90 | < 1% 6.37M to 6.38M | 2% |
| 26-Aug-21 7:29 PM View: | McIlwain Matthew S Director | Nautilus Biotechnology, Inc. (NAUT) | 25-Aug-21 | Market Purchase | 11,693 | $7.74 | $90,458.20 | < 1% 6.36M to 6.37M | 1% |
| 26-Aug-21 7:29 PM View: | McIlwain Matthew S Director | Nautilus Biotechnology, Inc. (NAUT) | 24-Aug-21 | Market Purchase | 13,568 | $7.68 | $104,269.00 | < 1% 6.34M to 6.36M | 2% |
| 13-Aug-21 9:01 PM View: | Murphy Matthew B. General Counsel | Nautilus Biotechnology, Inc. (NAUT) | 13-Aug-21 | Purchase | 5,000 | $7.56 | $37,806.50 | 17% 29.14K to 34.14K | |
| 16-Aug-21 5:12 PM View: | Mowry Anna CFO and Treasurer | Nautilus Biotechnology, Inc. (NAUT) | 12-Aug-21 | Purchase | 17,500 | $7.71 | $134,925.00 | 100% 0 to 17.5K | |
| 11-Jun-21 5:45 PM View: | Perceptive Advisors LLC | Nautilus Biotechnology, Inc. (NAUT) | 09-Jun-21 | Purchase | 5,500,000 | $10.00 | $55,000,000.00 | 141% 3.91M to 9.41M | |
| 11-Jun-21 5:32 PM View: | Altman Michael Seth Director | Nautilus Biotechnology, Inc. (NAUT) | 09-Jun-21 | Conversion | 499,000 | -- | -- | (50%) 998.0K to 499.0K | |
| 11-Jun-21 5:45 PM View: | Perceptive Advisors LLC | Nautilus Biotechnology, Inc. (NAUT) | 09-Jun-21 | Acquisition (other) | 2,914,110 | -- | -- | 293% 994.08K to 3.91M | |
| 03-Jun-21 6:55 PM View: | Perceptive Advisors LLC | Nautilus Biotechnology, Inc. (NAUT) | 03-Jun-21 | Purchase | 330,050 | $10.05 | $3,317,000.00 | 206% 159.93K to 489.98K | |
| 11-Jun-21 5:45 PM View: | Perceptive Advisors LLC | Nautilus Biotechnology, Inc. (NAUT) | 24-May-21 | Purchase | 7,063 | $10.05 | $70,983.10 | < 1% 987.01K to 994.08K | |
| 24-May-21 6:49 PM View: | Perceptive Advisors LLC Director | Nautilus Biotechnology, Inc. (NAUT) | 20-May-21 | Purchase | 159,925 | $10.05 | $1,607,250.00 | 100% 0 to 159.93K | |
| 11-Aug-20 8:38 PM View: | Altman Michael Seth Chief Financial Officer Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 11-Aug-20 | Acquisition (other) Duplicate | 499,000 | $10.00 | $4,990,000.00 | 100% 0 to 499.0K | |
| 11-Aug-20 8:43 PM View: | Stone Adam Leo Chief Executive Officer Director 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 11-Aug-20 | Acquisition (other) Duplicate | 499,000 | $10.00 | $4,990,000.00 | 100% 0 to 499.0K | |
| 11-Aug-20 8:48 PM View: | Arya Sciences Holdings III 10% Owner | Nautilus Biotechnology, Inc. (NAUT) | 11-Aug-20 | Acquisition (other) | 499,000 | $10.00 | $4,990,000.00 | 100% 0 to 499.0K |
